Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2025 Filed Aug 5, 2025 20:30 UTC |
Basile Edward MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,143 | Not disclosed Strike: $0.70 | Not disclosed |
DisclosureSEC source: 0000950170-25-103110 · ownership.xml · derivative · entry 3 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,142 Underlying: Common Stock · 4,143 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 20:30 UTC |
Basile Edward MDirector
|
SaleCommon Stock | 4,143 | $125.51 | $519,987.93 |
DisclosureSEC source: 0000950170-25-103110 · ownership.xml · nonDerivative · entry 2 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,866 Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 20:30 UTC |
Basile Edward MDirector
|
Exercise / conversionCommon Stock | 4,143 | $0.70 | $2,900.10 |
DisclosureSEC source: 0000950170-25-103110 · ownership.xml · nonDerivative · entry 1 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 20:44 UTC |
Ranganath Anil P.See remarks
|
SaleCommon Stock | 686 | $139.80 | $95,902.80 |
DisclosureSEC source: 0000950170-25-084405 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,955 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| May 27, 2025 Filed May 29, 2025 20:30 UTC |
Basile Edward MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | Not disclosed Strike: $0.70 | Not disclosed |
DisclosureSEC source: 0000950170-25-079022 · ownership.xml · derivative · entry 3 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,285 Underlying: Common Stock · 5,000 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 27, 2025 Filed May 29, 2025 20:30 UTC |
Basile Edward MDirector
|
SaleCommon Stock | 5,000 | $126.45 | $632,250.00 |
DisclosureSEC source: 0000950170-25-079022 · ownership.xml · nonDerivative · entry 2 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,866 Read SEC document |
| May 27, 2025 Filed May 29, 2025 20:30 UTC |
Basile Edward MDirector
|
Exercise / conversionCommon Stock | 5,000 | $0.70 | $3,500.00 |
DisclosureSEC source: 0000950170-25-079022 · ownership.xml · nonDerivative · entry 1 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2025 Filed May 23, 2025 22:41 UTC |
Weill DavidDirector
|
SaleCommon Stock | 732 | $123.88 | $90,680.16 |
DisclosureSEC source: 0000950170-25-077211 · ownership.xml · nonDerivative · entry 2 Weill David · CIK 0001774270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,134 Read SEC document |
| May 22, 2025 Filed May 23, 2025 22:46 UTC |
RAINES MERILEEDirector
|
GrantCommon Stock | 2,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077220 · ownership.xml · nonDerivative · entry 1 RAINES MERILEE · CIK 0001023869 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,059 F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 23, 2025 22:47 UTC |
TOBIN JAMES RDirector
|
GrantCommon Stock | 2,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077221 · ownership.xml · nonDerivative · entry 1 TOBIN JAMES R · CIK 0001190128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,059 F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 23, 2025 22:43 UTC |
Kania EdwinDirector
|
GrantCommon Stock | 2,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077213 · ownership.xml · nonDerivative · entry 1 KANIA EDWIN M JR · CIK 0001255927 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,810 F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 23, 2025 22:45 UTC |
Gunderson Thomas J.Director
|
GrantCommon Stock | 2,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077216 · ownership.xml · nonDerivative · entry 1 Gunderson Thomas James · CIK 0001708144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,059 F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 23, 2025 22:48 UTC |
Basile Edward MDirector
|
GrantCommon Stock | 2,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077227 · ownership.xml · nonDerivative · entry 1 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866 F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 23, 2025 22:48 UTC |
Lovell StephanieDirector
|
GrantCommon Stock | 2,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077225 · ownership.xml · nonDerivative · entry 1 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,059 F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 23, 2025 22:41 UTC |
Weill DavidDirector
|
GrantCommon Stock | 2,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077211 · ownership.xml · nonDerivative · entry 1 Weill David · CIK 0001774270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,866 F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:43 UTC |
Basile Edward MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $0.70 | Not disclosed |
DisclosureSEC source: 0000950170-25-070568 · ownership.xml · derivative · entry 3 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,285 Underlying: Common Stock · 6,000 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:43 UTC |
Basile Edward MDirector
|
SaleCommon Stock | 6,000 | $115.63 | $693,780.00 |
DisclosureSEC source: 0000950170-25-070568 · ownership.xml · nonDerivative · entry 2 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 732 Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:43 UTC |
Basile Edward MDirector
|
Exercise / conversionCommon Stock | 6,000 | $0.70 | $4,200.00 |
DisclosureSEC source: 0000950170-25-070568 · ownership.xml · nonDerivative · entry 1 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 16:30 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 2,407 | $76.43 | $183,967.01 |
DisclosureSEC source: 0000950170-25-033706 · ownership.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,042 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 23:16 UTC |
Hassanein Waleed HDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 90,185 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028069 · ownership.xml · derivative · entry 3 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,185 Underlying: Common Stock · 90,185 shares Expires 2035-02-25 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 25, 2025 until the option is fully vested on February 25, 2029, subject to continued service. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 23:16 UTC |
Hassanein Waleed HDirector · President & CEO
|
GrantCommon Stock | 59,781 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028069 · ownership.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,424 F1 · shares: Consists of 59,781 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:15 UTC |
Hernandez GerardoChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,299 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000950170-25-028063 · ownership.xml · derivative · entry 2 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,299 Underlying: Common Stock · 5,299 shares Expires 2035-02-24 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:15 UTC |
Hernandez GerardoChief Financial Officer
|
GrantCommon Stock | 3,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028063 · ownership.xml · nonDerivative · entry 1 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,984 F1 · shares: Consists of 3,521 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:07 UTC |
Khayal Tamer IChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 26,499 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000950170-25-028040 · ownership.xml · derivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,499 Underlying: Common Stock · 26,499 shares Expires 2035-02-24 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:07 UTC |
Khayal Tamer IChief Commercial Officer
|
GrantCommon Stock | 17,606 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028040 · ownership.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,449 F1 · shares: Consists of 17,606 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:12 UTC |
Corcoran NicholasSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 19,079 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000950170-25-028054 · ownership.xml · derivative · entry 2 Corcoran Nicholas · CIK 0001964148 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,079 Underlying: Common Stock · 19,079 shares Expires 2035-02-24 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:12 UTC |
Corcoran NicholasSee Remarks
|
GrantCommon Stock | 12,676 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028054 · ownership.xml · nonDerivative · entry 1 Corcoran Nicholas · CIK 0001964148 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,781 F1 · shares: Consists of 12,676 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:09 UTC |
Ranganath Anil P.See remarks
|
GrantStock Option (Right to Buy) · Derivative | 8,479 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000950170-25-028048 · ownership.xml · derivative · entry 2 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,479 Underlying: Common Stock · 8,479 shares Expires 2035-02-24 F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:09 UTC |
Ranganath Anil P.See remarks
|
GrantCommon Stock | 5,634 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028048 · ownership.xml · nonDerivative · entry 1 Ranganath Anil P. · CIK 0001980144 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,641 F1 · shares: Consists of 5,634 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 114 shares of Issuer's Common Stock acquired on December 31, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of July 1, 2024 to December 31, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2024. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 16:29 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,083 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000950170-25-004192 · ownership.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,167 Underlying: Common Stock · 1,083 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 16:29 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 1,083 | $80.05 | $86,694.15 |
DisclosureSEC source: 0000950170-25-004192 · ownership.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,843 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 16:29 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,083 | $13.28 | $14,382.24 |
DisclosureSEC source: 0000950170-25-004192 · ownership.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 23:48 UTC |
Hernandez GerardoChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,922 | $0.00 Strike: $69.84 | $0.00 |
DisclosureSEC source: 0000950170-24-135528 · ownership.xml · derivative · entry 2 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,922 Underlying: Common Stock · 18,922 shares Expires 2034-12-09 F2 · derivative.exercise_date: The option vests as to 25% of the shares underlying the option on December 2, 2025 and as to the remaining shares in equal monthly installments over three years thereafter, subject to Reporting Persons' continued service to the Issuer. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 23:48 UTC |
Hernandez GerardoChief Financial Officer
|
GrantCommon Stock | 12,463 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135528 · ownership.xml · nonDerivative · entry 1 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,463 F1 · shares: Consists of 12,463 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 18:00 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,084 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000950170-24-133392 · ownership.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,250 Underlying: Common Stock · 1,084 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 18:00 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 1,084 | $86.40 | $93,657.60 |
DisclosureSEC source: 0000950170-24-133392 · ownership.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,843 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $86.21 to $86.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 18:00 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,084 | $13.28 | $14,395.52 |
DisclosureSEC source: 0000950170-24-133392 · ownership.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 16:30 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,458 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000950170-24-126397 · ownership.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 1,458 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 16:30 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 1,458 | $90.04 | $131,278.32 |
DisclosureSEC source: 0000950170-24-126397 · ownership.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,843 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 16:30 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,458 | $38.46 | $56,074.68 |
DisclosureSEC source: 0000950170-24-126397 · ownership.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:30 UTC |
Basile Edward MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,750 | $0.00 Strike: $28.12 | $0.00 |
DisclosureSEC source: 0000950170-24-123425 · ownership.xml · derivative · entry 4 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,750 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:30 UTC |
Basile Edward MDirector
|
SaleCommon Stock | 1,454 | $84.30 | $122,572.20 |
DisclosureSEC source: 0000950170-24-123425 · ownership.xml · nonDerivative · entry 3 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 732 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.00 to $84.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:30 UTC |
Basile Edward MDirector
|
SaleCommon Stock | 5,296 | $83.35 | $441,421.60 |
DisclosureSEC source: 0000950170-24-123425 · ownership.xml · nonDerivative · entry 2 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,186 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.91 to $83.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:30 UTC |
Basile Edward MDirector
|
Exercise / conversionCommon Stock | 6,750 | $28.12 | $189,810.00 |
DisclosureSEC source: 0000950170-24-123425 · ownership.xml · nonDerivative · entry 1 Basile Edward M · CIK 0001773661 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 16:30 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,083 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000950170-24-121525 · ownership.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,334 Underlying: Common Stock · 1,083 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 16:30 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 1,083 | $82.64 | $89,499.12 |
DisclosureSEC source: 0000950170-24-121525 · ownership.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,843 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.55 to $82.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 16:30 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,083 | $13.28 | $14,382.24 |
DisclosureSEC source: 0000950170-24-121525 · ownership.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:30 UTC |
Hassanein Waleed HDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,625 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000950170-24-115332 · ownership.xml · derivative · entry 7 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,250 Underlying: Common Stock · 8,625 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:30 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 300 | $135.04 | $40,512.00 |
DisclosureSEC source: 0000950170-24-115332 · ownership.xml · nonDerivative · entry 5 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,643 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $134.63 to $135.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:30 UTC |
Hassanein Waleed HDirector · President & CEO
|
SaleCommon Stock | 1,200 | $134.23 | $161,076.00 |
DisclosureSEC source: 0000950170-24-115332 · ownership.xml · nonDerivative · entry 4 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,943 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $133.57 to $134.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.